DuOtic received FDA approval March 2024 to treat canine patients
Pharmacology
Latest News
Advertisement
CE Content
Advertisement
Casey Locklear, DVM, discussed the combination drug’s efficacy and administration of the therapy, during an interview with dvm360.
These natural and pharmaceutical therapies aid by reducing the reabsorption of sodium and water
Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session
Casey Locklear, DVM, discussed Credelio Quattro chewable tablets in a dvm360 interview.
Loyal’s developmental therapy aims to increase longevity and quality of life for senior dogs
The novel therapy is the first drug for treating cats with hypertrophic cardiomyopathy
Casey Locklear, DVM, discusses Elanco's new product Credelio Quattro, which will be featured at WVC 2025
American Regent Animal Health created the new resources in collaboration with the UC-Davis professor Denis Marcellin-Little, DEDV, DACVS, DACVSMR, DECVS
Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval
Approved by the FDA in January 2024, EquiCoxib is a noninvasive, liquid formulation.
The legislation seeks to empower law enforcement and fight the opioid epidemic while also protecting access to the drug for veterinary use
Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has been collected in the past year.
Revelation Animal Health, part of the compounding pharmacy network Revelation Pharma, will debut at the 2025 VMX event in Orlando, Florida.
At VMX, Virbac is launching an oral product featuring ursolic acid, in collaboration with Emmyon Inc.
Indications are broadened for Zoetis products to include new protections against Asian longhorned ticks and tapeworms
Integrative therapies can enhance a patient’s survival and quality of life
FDA notifies veterinarians of adverse events linked to canine osteoarthritis treatment
Published: | Updated:
Neurologic signs were reported with bedinvetmab injection use in dogs
dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights
The Top 5 countdown for 2024 dvm360 videos highlights the most viewed interviews of the past year
dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights
dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights
dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights
dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights
Advertisement
Advertisement
Trending on dvm360
1
AAHA releases new diabetes management guidelines for dogs
2
FDA emergency authorizes Capstar, generic nitenpyram to prevent and treat New World screwworm in dogs and cats
3
Moving the Needle - Helping Pet Owners Through Vaccine Hesitancy
4
Using combination diets to tackle joints, derm, and kidneys together
5